948 Final results from AIPAC: A phase IIb comparing eftilagimod alpha (a soluble LAG-3 protein) vs. placebo in combination with weekly paclitaxel in HR+ HER2- MBC
oleh: Christian Mueller, Frederik Marmé, Luc Dirix, Frederic Triebel, Hans Wildiers, Peter Vuylsteke, Chrystelle Brignone, Jens Huober, Sherko Kümmel, Anne Armstrong, Eveline De Cuypere, Florence Dalenc, Steven Chan, Carolina Pia Schröder, Jean-Philippe Jacquin, Etienne Brain, Zsuzsanna Pápai
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.